当前位置: X-MOL 学术Pediatr. Hematol. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Predictive factors for adverse outcome of advanced-stage childhood lymphoblastic lymphoma: a single tertiary center retrospective study in Thailand
Pediatric Hematology and Oncology ( IF 1.2 ) Pub Date : 2021-08-11 , DOI: 10.1080/08880018.2021.1963360
Shevachut Chavananon 1 , Pornpun Sripornsawan 1 , Edward B McNeil 2 , Thirachit Chotsampancharoen 1
Affiliation  

ABSTRACT

Childhood lymphoblastic lymphoma (LL) is a highly aggressive neoplasm which has achieved favorable survival outcomes in many developed countries. However, few studies have reported treatment outcomes of childhood LL in resource-limited counties, nor has a prognostic scoring system been developed. The objectives of this study were to evaluate survival outcomes and identify prognostic factors associated with inferior outcomes of childhood LL in a referral center in March 1985 and April 2017 were retrospectively reviewed. Seventy-five advanced-stage LL patients were included, 47 (62.7%) of whom had stage IV at initial diagnosis. The 5-year DFS and OS rates were 44.6% and 44.7%, respectively. There were 3 significant prognostic factors associated with worse outcomes: presence of B symptoms, low albumin level < 3.5 g/dL and serum LDH level > 500 IU/L. From these three factors, we assigned a score of 1 for each and total scores of 0, 1, 2, and 3 could predict 5-year OS rates of 92.3%, 50.9%, 24.7% and 0%, respectively (p < 0.05). The survival of children in this study was lower than in other studies of advanced-stage childhood LL. We identified 3 adverse prognostic factors and developed a prognostic model for clinical use in advanced-stage childhood LL.



中文翻译:

晚期儿童淋巴母细胞淋巴瘤不良结局的预测因素:泰国单一三级中心回顾性研究

摘要

儿童淋巴母细胞淋巴瘤 (LL) 是一种高度侵袭性的肿瘤,在许多发达国家都取得了良好的生存结果。然而,很少有研究报告资源有限县儿童 LL 的治疗结果,也没有开发预后评分系统。本研究的目的是评估生存结果并确定与 1985 年 3 月和 2017 年 4 月转诊中心儿童 LL 不良结果相关的预后因素。包括 75 名晚期 LL 患者,其中 47 名(62.7%)在初始诊断时为 IV 期。5 年 DFS 和 OS 率分别为 44.6% 和 44.7%。有 3 个显着的预后因素与较差的结果相关:存在 B 症状、低白蛋白水平 < 3.5 g/dL 和血清 LDH 水平 > 500 国际单位/升。从这三个因素中,我们为每个因素分配了 1 分,总分 0、1、2 和 3 可以预测 5 年 OS 率分别为 92.3%、50.9%、24.7% 和 0%(p <  0.05)。本研究中儿童的存活率低于其他晚期儿童 LL 研究。我们确定了 3 个不良预后因素,并开发了一个用于晚期儿童 LL 临床使用的预后模型。

更新日期:2021-08-11
down
wechat
bug